ASC-101

· Targazyme, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASC-101, covering 2013-11-18 to 2013-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation [Phase 1, Phase 2]

See pricing